The Calmer Co raises $1.6m to accelerate U.S. kava expansion

Fiji Kava Limited ( (AU:CCO) ) has shared an update.

The Calmer Co International has raised $1.6 million in an oversubscribed placement to sophisticated and professional investors, with Novus Capital as lead manager, to fund inventory build, sales, distribution and marketing. The capital will support large-scale U.S. wholesale supply contracts, expansion on Amazon USA and direct-to-consumer channels, and further penetration of Australian retail.

Management says the funding strengthens the balance sheet, underpins inventory expansion to service rising U.S. demand and helps the business move toward operational break-even as revenue scales. In the context of a global kava extract market forecast to grow strongly, the raise is intended to cement The Calmer Co’s leadership in functional relaxation and alcohol alternatives, accelerating its U.S. growth and positioning it to capture structural shifts in consumer behaviour.

The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.

More about Fiji Kava Limited

The Calmer Co International Limited, listed on the ASX, operates in the functional wellness and alcohol-alternative sector, producing kava-based products for relaxation, sleep support and social drinking occasions. Leveraging a 15-year vertically integrated Pacific Island supply chain across Fiji, Solomon Islands and PNG, proprietary CO₂ extraction technology and Australian supermarket partnerships with Woolworths and Coles, the company targets the fast-growing global kava extract market, particularly in the U.S.

Technical Sentiment Signal: Sell

Current Market Cap: A$12.23M

See more data about CCO stock on TipRanks’ Stock Analysis page.